Phil Newman

About

Editor-in-Chief Phil has over 25 years of C-level management, marketing and business development expertise in Europe and North America. His creative background has helped him shape unconventional strategies for commercial growth - garnering both awards and investor ROI.

Phil has wide experience of technology transfer and the commercialisation of innovations from both private and institutional sources and this led to his interest in Longevity and the founding of Longevity.Technology.
122 POSTS

/

0 COMMENTS

Articles

Help us help you: Longevity biotech survey

A new survey on translational processes and hurdles to clinical trials in Longevity biotech. We're working with two MDs: Oliver Zolman and Jian Fransen, on...

First Longevity announces first investors for current round

Some news of our own: European VC fund and a Longevity innovator participate in the First Longevity funding round. Last week we announced that Tom...

Hyperbaric oxygen could improve cognitive ability

The hyperbaric oxygen market is growing rapidly as scientists discover more uses in preventing cognitive decline. An innovative form of hyperbaric oxygen therapy (HBOT)...

Heart surgeons endorse xenotransplantation

A survey of attitudes among heart surgeons shows most are supportive of xenotransplantation. According to a new survey, more than 80% of heart surgeons believe...

Researchers heal human lungs by attaching them to pigs

A new breakthrough from researchers at Columbia University could dramatically increase the number of lungs available for transplant. One of the biggest challenges for lung...

Researchers 3D bio-print a working heart pump with real human cells

Team at the University of Minnesota 3D bio-print a functioning heart pump in the lab. Scientists at the University of Minnesota have made a breakthrough...

Magical hydrogel mimics cartilage to promote healthspan

A new form of hydrogel promises to go where other forms haven’t by mimicking the near-magical qualities of cartilage. Researchers at Duke University believe they...

Exclusive video interview: David Wood demystifies the transhumanist agenda

As Longevity moves quickly into the mainstream there are terms and legacies that some use to challenge the sector's validity: we explore what it...

The results are in: sharing our Longevity investment survey

There is rapidly-increasing activity in both the research and the investment communities that focus on Longevity; this survey gets into the details. The global Longevity...